Matches in Nanopublications for { ?s ?p "[alpha, beta, and gamma synuclein are expressed in a high percentage of ovarian and breast carcinomas, and abnormal gamma synuclein expression may occur early in the development of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP765658.RABUAEBRsOkG3FlqWlGv1uWh9rm4mSxm43pkW693EIeyM130_assertion description "[alpha, beta, and gamma synuclein are expressed in a high percentage of ovarian and breast carcinomas, and abnormal gamma synuclein expression may occur early in the development of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP765658.RABUAEBRsOkG3FlqWlGv1uWh9rm4mSxm43pkW693EIeyM130_provenance.
- NP284088.RADcDp515CAUblrusCvtaU4bQOM3AkUP0tLNtH5916pNA130_assertion description "[alpha, beta, and gamma synuclein are expressed in a high percentage of ovarian and breast carcinomas, and abnormal gamma synuclein expression may occur early in the development of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284088.RADcDp515CAUblrusCvtaU4bQOM3AkUP0tLNtH5916pNA130_provenance.
- NP704943.RA2slFsMXfCCOgCQjnQOvHLCRUjSeGM9XEV4tmI6wq3zM130_assertion description "[alpha, beta, and gamma synuclein are expressed in a high percentage of ovarian and breast carcinomas, and abnormal gamma synuclein expression may occur early in the development of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP704943.RA2slFsMXfCCOgCQjnQOvHLCRUjSeGM9XEV4tmI6wq3zM130_provenance.
- NP704971.RA4QU8ZuF1WgqBDKmNIzqyYDSMCXwuLGEA9y5G-hcEznY130_assertion description "[alpha, beta, and gamma synuclein are expressed in a high percentage of ovarian and breast carcinomas, and abnormal gamma synuclein expression may occur early in the development of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP704971.RA4QU8ZuF1WgqBDKmNIzqyYDSMCXwuLGEA9y5G-hcEznY130_provenance.
- NP284090.RA637mJD19sWsK-mUYToDA0Bdas34ZEa1C7EmOOQS-wsc130_assertion description "[alpha, beta, and gamma synuclein are expressed in a high percentage of ovarian and breast carcinomas, and abnormal gamma synuclein expression may occur early in the development of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284090.RA637mJD19sWsK-mUYToDA0Bdas34ZEa1C7EmOOQS-wsc130_provenance.
- assertion description "[alpha, beta, and gamma synuclein are expressed in a high percentage of ovarian and breast carcinomas, and abnormal gamma synuclein expression may occur early in the development of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[alpha, beta, and gamma synuclein are expressed in a high percentage of ovarian and breast carcinomas, and abnormal gamma synuclein expression may occur early in the development of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[alpha, beta, and gamma synuclein are expressed in a high percentage of ovarian and breast carcinomas, and abnormal gamma synuclein expression may occur early in the development of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP284086.RAHTHKflcXyvWS2h9QiSKEu9_hy9lJeW76AZGkUBdWeXE130_assertion description "[alpha, beta, and gamma synuclein are expressed in a high percentage of ovarian and breast carcinomas, and abnormal gamma synuclein expression may occur early in the development of ovarian carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284086.RAHTHKflcXyvWS2h9QiSKEu9_hy9lJeW76AZGkUBdWeXE130_provenance.